These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29475111)

  • 1. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.
    Brent MB; Brüel A; Thomsen JS
    Bone; 2018 May; 110():244-253. PubMed ID: 29475111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
    Vegger JB; Nielsen ES; Brüel A; Thomsen JS
    Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
    Brent MB; Thomsen JS; Brüel A
    Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
    Sørensen TG; Brent MB; Thomsen JS; Brüel A
    Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
    Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS
    Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats.
    Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A
    J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats.
    Brent MB; Brüel A; Thomsen JS
    Bone; 2022 Jul; 160():116417. PubMed ID: 35398589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.
    Laurent MR; Jardí F; Dubois V; Schollaert D; Khalil R; Gielen E; Carmeliet G; Claessens F; Vanderschueren D
    Bone; 2016 Dec; 93():33-42. PubMed ID: 27622887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice.
    Brent MB; Lodberg A; Bromer FD; van der Eerden BCJ; Eijken M; Brüel A; Thomsen JS
    Bone; 2021 Jan; 142():115692. PubMed ID: 33069923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia.
    Mosekilde L; Tornvig L; Thomsen JS; Orhii PB; Banu MJ; Kalu DN
    Bone; 2000 Jun; 26(6):643-51. PubMed ID: 10831937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.
    Libouban H; Blouin S; Moreau MF; Baslé MF; Audran M; Chappard D
    Micron; 2008 Oct; 39(7):998-1007. PubMed ID: 18023586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertical Trabeculae are Thinned More Than Horizontal Trabeculae in Skeletal-Unloaded Rats.
    Vegger JB; Brüel A; Thomsen JS
    Calcif Tissue Int; 2015 Nov; 97(5):516-26. PubMed ID: 26163234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats.
    Ornstrup MJ; Brüel A; Thomsen JS; Harsløf T; Langdahl BL; Pedersen SB
    Calcif Tissue Int; 2018 Mar; 102(3):337-347. PubMed ID: 29058054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A.
    Brent MB; Lodberg A; Thomsen JS; Brüel A
    MethodsX; 2020; 7():101079. PubMed ID: 33083241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate and combined effects of growth hormone and parathyroid hormone on cortical bone osteopenia in ovariectomized aged rats.
    Banu MJ; Orhii PB; Wang L; Kalu DN
    Aging (Milano); 2001 Aug; 13(4):282-92. PubMed ID: 11695497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.